• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

New data on prevalence and spectrum of germline mutations in pediatric cancer patients

byMatthew Lin, MDandShaidah Deghan, MSc. MD
November 19, 2015
in Chronic Disease, Oncology, Pediatrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

 

1. Significantly higher prevalence of germline mutations in cancer-predisposition syndrome genes identified in pediatric cancer patients compared with non-cancer adult patients.

2. New associations between germline mutations identified for TP53, PMS2 and RET and Ewing’s sarcoma and APC and SDHB mutations with neuroblastoma.

Evidence Rating: 2 (Good)    

Study Rundown: The prevalence of germline mutations in cancer-associated or cancer-predisposition genes has not been thoroughly documented in the medical literature. Existing studies have relied primarily on candidate-gene approaches as opposed to next-generation sequencing. In this cross-sectional study, the researchers use whole-genome and whole-exome sequencing in pediatric cancer patients to analyze the prevalence and breadth of germline mutations in cancer-associated genes. The researchers notably found that 8.5% of the study participants had predisposing genetic mutations, primarily for genes associated with autosomal-dominant cancer syndromes. The researchers also found new mutations associated with Ewing’s sarcoma and neuroblastoma and through review of medical and family history, found that only half of the patients with pathogenic or probably pathogenic germline mutations had a family history consistent with their condition. Limitations of this study include the potential under-estimation of germline mutations, as pathogenic and probably pathogenic genes were selected based on a priori knowledge of the gene’s relevance to certain cancer syndromes. With regards to practice implications, this study has highlighted several new associations between germline mutations and cancers such as Ewing’s Sarcoma and neuroblastoma.

Click to read the study, published today in NEJM

Relevant Reading: ACGM recommendations for reporting of incidental findings in clinical exome and genome sequencing

RELATED REPORTS

2 Minute Medicine Rewind May 22nd, 2022

#VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma

Virtual yoga and meditation intervention may be associated with increased health-related quality of life

In-Depth [cross-sectional study]: The prevalence of germline mutations in 1120 pediatric cancer patients (<20 years of age) were evaluated in this study. Either whole genome sequencing (n=595), whole exome sequencing (n=456) or both (n=69) were performed on participants. Specific analyses for single-nucleotide variants, small insertions and deletions and germline mosaicism were performed on 565 genes, 60 of which have been linked to autosomal dominant (AD) cancer syndromes and 29 of which have been linked to autosomal recessive (AR) cancer syndromes. The researchers also used two control groups: whole-exome sequencing of 966 unrelated adults (Genomes Project-GP) and a second data set of 515 persons with autism and 208 persons without autism. Genetic variants were coded as either pathogenic, probably pathogenic, of uncertain significant, probably benign or benign based on expert panel consensus. Of the 60 genes associated with AD cancer syndromes, 78 (12%) were identified as pathogenic and 17 (12%) were identified as probably pathogenic. The most common genes implicated in this analysis were TP54 (in 50), APC (in 6) and BRCA2 (in 6). The GP and autism control data sets had 1.1% and 0.6% pathogenic or probably pathogenic mutations of the 60 genes associated with AD cancer syndromes, respectively – both significantly lower result compared to the pediatric group. Of the AR cancer syndrome genes, only 1 patient had a pathogenic mutation. Across tumor types, pathogenic or probably pathogenic germline mutations were most commonly found in patients with non-CNS solid tumors (in 48/287, 16.7%) and CNS tumors (in 21/245, 8.6%). The researchers also found new correlations between germline mutations in TP53, PMS2 and RET in Ewing’s sarcoma patients and APC and SDHB mutations in neuroblastoma patients. Only half of the participants had a family history consistent with a known cancer-predisposition.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

Community treatment of HIV pre-exposure prophylaxis demonstrated low acquisition rate but disparities in adherence

Next Post

Sofosbuvir-velpatasvir may provide sustained virologic response in Hepatitis C cirrhotics: The ASTRAL-4 study

RelatedReports

Weekly Rewinds

2 Minute Medicine Rewind May 22nd, 2022

May 23, 2022
#VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
StudyGraphics

#VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma

May 20, 2022
Exercise intervention linked to reduced functional decline among elderly patients admitted to the hospital
Wellness

Virtual yoga and meditation intervention may be associated with increased health-related quality of life

May 20, 2022
Association of Use of Oral Contraceptives With Depressive Symptoms Among Adolescents and Young Women
Wellness

Wellness Check: Mental Health

May 19, 2022
Next Post
[CORAL-1 trial] Interferon-free regimen for recurrent hepatitis C after liver transplant safe and effective

Sofosbuvir-velpatasvir may provide sustained virologic response in Hepatitis C cirrhotics: The ASTRAL-4 study

Adverse pregnancy outcomes associated with thrombophilias [Classics Series]

The SOME trial: Screening for occult malignancy in unprovoked venous thromboembolism [Classics Series]

Adverse pregnancy outcomes associated with thrombophilias [Classics Series]

The Magpie trial: Magnesium lowers eclampsia risk [Classics Series]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind May 22nd, 2022
  • #VisualAbstract: Severe actinic keratosis and need for additional treatment are markers for an increased risk of cutaneous squamous cell carcinoma
  • Virtual yoga and meditation intervention may be associated with increased health-related quality of life
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.